tag: why it’s moving

Citius Pharmaceuticals Announces $5 Million Registered Direct Offering to Support Lymphir Launch On April 24, 2026, Citius Pharmaceuticals Inc. (Nasdaq: CTXR) announced a registered direct offering expected to generate approximately …

Understanding Pinterest Insider Activity: Analyzing Recent Form 4 Filings Investor attention often turns to SEC Form 4 filings to gauge the sentiment of a company’s leadership. Recent filings for Pinterest …